Back to search

Japan· JP-2439402G1029

テリパラチド(遺伝子組換え)[テリパラチド後続1]

A medicinal product containing テリパラチド(遺伝子組換え)[テリパラチド後続1], registered in Japan by 持田製薬, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedテリパラチド(遺伝子組換え)[テリパラチド後続1]ATC—REGISTER NO.JP-2439402G1029PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
テリパラチド(遺伝子組換え)[テリパラチド後続1]
Manufacturer
持田製薬
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

テリパラチド(遺伝子組換え)[テリパラチド後続1] in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All テリパラチド(遺伝子組換え)[テリパラチド後続1] products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Teriparatid +pharma, Teriparatid Cipla
  • Bulgaria · Osteoteri
  • Cyprus · Bonamens
  • Germany · Osteoteri, Teriparatid Ambio Pharma
  • Denmark · Tetridar
  • Spain · Duratil, Osdy
  • France · Teriparatide Ambio Pharma, Teriparatide Biogaran
  • United Kingdom (Northern Ireland) · Movymia, Teriparatide Ambio Pharma
  • Greece · Bonamens, Osteorel
  • Croatia · Teriparatid Pliva
  • Hungary · Osteoteri, Teriparatid Teva
  • Ireland · Teriparatide Cipla, Tetridar
  • Iceland · Forsteo, Kauliv
  • Italy · Oseffyl, Patride
  • Liechtenstein · Forsteo, Kauliv
  • Netherlands · Teriparatide Ambio Pharma, Teriparatide Aristo
  • Norway · Forsteo, Kauliv
  • Poland · Osteoteri
  • Portugal · Teriparatida Ratiopharm
  • Sweden · Teriparatide Ambio Pharma, Teriparatide Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7eefa16-4900-4888-99c1-74b2afd70e1f
GET /v1/drugs/c7eefa16-4900-4888-99c1-74b2afd70e1f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "600μg1キット",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2439402G1029",
  "category": "注射薬",
  "price_yen": 14924,
  "generic_name": "テリパラチド(遺伝子組換え)[テリパラチド後続1]",
  "product_name_jp": null,
  "therapeutic_class": "2439",
  "transitional_expiry": null
}

See everything about テリパラチド(遺伝子組換え)[テリパラチド後続1].

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.